Cancer Incidence for the City of Syracuse, 2004-2008
Source: New York State Cancer Registry
| Site of Cancer | Males | Females | ||||
|---|---|---|---|---|---|---|
| Average Annual Cases | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Cases | Rate per 100,000 Females | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 378.8 | 671.6 | 30.2 | 348.4 | 438.7 | 20.6 |
| Oral cavity and pharynx | 13.6 | 23.8 | 5.7 | 7.0 | 9.0 | 3.0 |
| Esophagus | 6.4 | 11.0 | 3.8 | 1.8 | 2.4 | 1.6 |
| Stomach | 4.4 | 7.8 | 3.3 | 3.8 | 4.2 | 1.9 |
| Colorectal | 33.0 | 58.3 | 8.9 | 34.2 | 38.9 | 5.8 |
| Colon excluding rectum | 22.4 | 40.0 | 7.4 | 25.0 | 27.6 | 4.8 |
| Rectum & rectosigmoid | 10.6 | 18.3 | 4.9 | 9.2 | 11.3 | 3.3 |
| Liver / intrahepatic bile duct | 11.0 | 18.5 | 4.9 | 3.2 | 4.2 | 2.1 |
| Pancreas | 9.6 | 17.2 | 4.9 | 9.2 | 9.9 | 2.9 |
| Larynx | 7.6 | 13.8 | 4.4 | 1.2 | 1.5 | 1.2 |
| Lung and bronchus | 70.8 | 126.9 | 13.2 | 60.2 | 76.5 | 8.6 |
| Melanoma of the skin | 7.4 | 12.6 | 4.1 | 6.2 | 7.9 | 2.8 |
| Female breast | 88.4 | 116.6 | 10.9 | |||
| Cervix uteri | 7.0 | 10.5 | 3.5 | |||
| Corpus uterus and NOS | 19.2 | 26.3 | 5.3 | |||
| Ovary | 8.6 | 11.0 | 3.3 | |||
| Prostate | 105.4 | 192.3 | 16.4 | |||
| Testis | 4.8 | 7.0 | 2.8 | |||
| Urinary bladder (incl. in situ) | 24.0 | 42.5 | 7.6 | 9.2 | 10.9 | 3.1 |
| Kidney and renal pelvis | 10.6 | 18.8 | 5.1 | 12.0 | 15.3 | 3.9 |
| Brain and other nervous system | 3.8 | 6.2 | 2.8 | 5.6 | 7.3 | 2.7 |
| Thyroid | 3.4 | 5.6 | 2.7 | 9.8 | 13.7 | 3.8 |
| Hodgkin lymphoma | 3.4 | 5.2 | 2.5 | 1.2 | 1.5 | 1.2 |
| Non-Hodgkin lymphomas | 15.6 | 27.3 | 6.1 | 12.6 | 15.7 | 3.9 |
| Multiple myeloma | 3.4 | 6.4 | 3.0 | 7.0 | 8.9 | 2.9 |
| Leukemias | 10.4 | 17.7 | 4.8 | 7.8 | 8.2 | 2.6 |
Notes
- Incidence data are provisional, November 2010.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
